Charlotte Foissard

❖ Development of new products (NPI) using HTRF technology (Development) ❖ Identification of new biological targets (Strategy & Sourcing)

↦ Project management ↦ Development of HTRF assays: proof of concept, pharmacological validation, packaging, transfer to production ↦ Documentation and release of kits according to ISO9001 ↦ NPI request study: bibliographic and bioinformatics analysis, definition of specifications, selection and ordering of raw materials according to budgets and administrative standards, transfer to development teams ↦ Relations with other departments (Product Manager, Marketing and Production) ↦ Management of technicians ↦ Cross-functional working groups: Biosafety, Waste Management, skills=[]

❖ Release of active pharmaceutical ingredient batches intended for the pharmaceutical industry

↦ Project management: Implementation of new standards, client services. ↦ Application of GMP standards and documentation management. ↦ External relations (regulatory and clients). ↦ Analytical troubleshooting. ↦ Analysis, documentation and release of batches. ↦ Supervision of a team of technicians.

❖ European PEVIA project

❖ Mobilization of the laboratory to respond to the SARS CoV2 health crisis

❖ Projects related to CBRN-E risks (Nuclear, Radiological, Biological, Chemical, and Explosives)

↦ Production of antigens (retroviral pseudotypes and viruses). ↦ Development of in vitro tests to detect and quantify neutralizing antibodies against Ebola virus. ↦ Implementation of cell culture techniques in Cell Factory for pseudotype production. ↦ Implementation of new flow cytometry equipment. ↦ Writing of deliverable and project progress reports. ↦ Interactions with project partners.

↦ Supervision of interns.